Live Breaking News & Updates on Proprietary Technology|Page 3

Stay updated with breaking news from Proprietary technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

WPP plc (NYSE:WPP) Q4 2023 Earnings Call Transcript

WPP plc (NYSE:WPP) Q4 2023 Earnings Call Transcript February 22, 2024 WPP plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Mark Read: Thank you very much and welcome everybody to WPP’s Preliminary Results for 2023. I’m Mark Read. I’m joined […] ....

United States , Laura Metayer , Mark Read , Krispy Kreme , Most Valuable Luxury Companies , Morgan Stanley , Capital Markets Day , Capital Markets , Super Bowl , Forbes Magazine , Progressive Insurance , Ogilvy One , Valuable Luxury Companies , Back Out , Wpp Plc , Joanne Wilson , Profitable Growth , Operating Margin , Mark Read , Basis Points , Proprietary Technology , Capital Markets Day , Operating Cash Flow ,

Motive countersues fleet tech rival Samsara over patent infringement

Fleet telematics provider Motive Technologies filed a lawsuit Thursday alleging Samsara Inc. copied and used its proprietary technology and patents. The post Motive countersues fleet tech rival Samsara over patent infringement appeared first on FreightWaves. ....

United States , San Francisco , Adam Simons , Shoaib Makani , Us International Trade Commission , Us District Court , Samsara Inc , Emotive Technologies , Northern District , Trade Commission , Vehicle Gateway , Proprietary Technology , Patent Infringement , Us District Court ,

iNtRON, Development of PHAGERIA® Anti-Cancer Candidate with Enhanced Antimicrobial Activity by Robot Bacteriophage platform technology

▶ Robot Bacteriophage against microbiome associated with colorectal cancer ▶ Bacteriophage Improvement Platform technology with a broad antimicrobial activity ▶ Proprietary Technology incorporating CRISPR/Cas Technology BOSTON, Feb. 15, 2024 /PRNewswire/ iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that New Drug Part has secured a potent anti-cancer candidate, PHAGERIA®, with broad antimicrobial activity against ETBF (Enterotoxigenic B. fragilis), a. ....

United States , Cas Technology , Bd Department , Robot Bacteriophage , Bacteriophage Improvement Platform , Proprietary Technology , New Drug Part , Random Transposon Mutagenesis , Robotic Bacteriophage , Robotic Bacteriophage Improvement Platform ,

Enova International Inc CFO Steven Cunningham Sells 17,548 Shares

Steven Cunningham, the Chief Financial Officer of Enova International Inc, executed a sale of 17,548 shares of the company on February 9, 2024, according to a recent SEC Filing. ....

Enova International Inc , Gurufocus Value , Steven Cunningham , Proprietary Technology ,

Former CooperVision Leader Tom Bender Joins MediPrint Ophthalmics as Strategic Advisor

SAN DIEGO, February 13, 2024 Tom Bender, former CooperVision exec, joins MediPrint Ophthalmics as an advisor for innovative drug-delivering contact lenses. ....

San Diego , United States , Praful Doshi , Tom Bender , Thomas Bender , Cooper Companies , Industry Veteran , Guide Drug Eluting Contact Lens , Mediprint Ophthalmics , Herbert Labs , Print Ophthalmics , Ocular Hypertension , Tom Bender , Mediprint Ophthalmics , Proprietary Technology , Contact Lens , Ophthalmic Pharmaceuticals , Drug Delivery , Business Wire , Laucoma Medication ,